Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies

Glioblastoma (GBM) is an aggressive brain malignancy with a dismal prognosis. With emerging evidence to disprove brain-immune privilege, there has been much interest in examining immunotherapy strategies to treat central nervous system (CNS) cancers. Unfortunately, the limited success of clinical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratnam, Nivedita M., Sonnemann, Heather M., Frederico, Stephen C., Chen, Huanwen, Hutchinson, Marsha-Kay N. D., Dowdy, Tyrone, Reid, Caitlin M., Jung, Jinkyu, Zhang, Wei, Song, Hua, Zhang, Meili, Davis, Dionne, Larion, Mioara, Giles, Amber J., Gilbert, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320893/
https://www.ncbi.nlm.nih.gov/pubmed/34336705
http://dx.doi.org/10.3389/fonc.2021.719091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320893/
https://www.ncbi.nlm.nih.gov/pubmed/34336705
http://dx.doi.org/10.3389/fonc.2021.719091

Ejemplares similares